Comparative Review of Pharmacovigilance System in Different Countries

This comparative review explores the pharmacovigilance systems in India, China, Germany, Bangladesh, Italy,Vietnam, Saudi Arabia. The analysis focuses on regulatory frameworks, adverse event reporting processes, data collection methodologies, and technological advancements in drug safety monitoring. By assessing the effectiveness of each country's system, the review identifies strengths, weaknesses, and unique approaches to pharmacovigilance. Key factors such as public awareness, healthcare provider involvement, and the integration of real-world evidence are discussed. The findings aim to highlight best practices and suggest improvements, contributing to enhanced drug safety and patient protection worldwide.